ISPOR 2024 Home
Toggle navigation
About
News Center
Award Winners
Program
Program
Learning Formats
Plenary Sessions
Posters
Program Committee
Digital Conference Pass
Exhibits & Sponsorship
Sponsor List
Exhibitor Directory
Media Partners
Photo Gallery
ISPOR
2024
May 5-8, 2024
Home
Events
Past Conferences
ISPOR 2024
Program
Plenary Sessions
Session
Healthcare Utilization and Costs Among Patients With Episodic Migraine Initiating Galcanezumab Versus Rimegepant for Migraine Prevention in the United States
May 8, 2024, 10:00 AM
«
271
272
(current)
273
274
275
276
277
278
279
280
»